The US Food and Drug Administration withdrew approval for this medication in October 2005 because of the risk for liver toxicity.
This medicine, which had been used to treat attention deficit hyperactivity disorder (ADHD) was found to be associated with liver failure and has been taken off the market in the US.
|
